Menu
GWAS Study

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn's disease.

González-Serna D, Ochoa E, López-Isac E et al.

32024964 PubMed ID
GWAS Study Type
24890 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GD
González-Serna D
OE
Ochoa E
LE
López-Isac E
JA
Julià A
DF
Degenhardt F
ON
Ortego-Centeno N
RT
Radstake TRDJ
FA
Franke A
MS
Marsal S
MM
Mayes MD
MJ
Martín J
MA
Márquez A
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies (GWASs) have identified a number of genetic risk loci associated with systemic sclerosis (SSc) and Crohn's disease (CD), some of which confer susceptibility to both diseases. In order to identify new risk loci shared between these two immune-mediated disorders, we performed a cross-disease meta-analysis including GWAS data from 5,734 SSc patients, 4,588 CD patients and 14,568 controls of European origin. We identified 4 new loci shared between SSc and CD, IL12RB2, IRF1/SLC22A5, STAT3 and an intergenic locus at 6p21.31. Pleiotropic variants within these loci showed opposite allelic effects in the two analysed diseases and all of them showed a significant effect on gene expression. In addition, an enrichment in the IL-12 family and type I interferon signaling pathways was observed among the set of SSc-CD common genetic risk loci. In conclusion, through the first cross-disease meta-analysis of SSc and CD, we identified genetic variants with pleiotropic effects on two clinically distinct immune-mediated disorders. The fact that all these pleiotropic SNPs have opposite allelic effects in SSc and CD reveals the complexity of the molecular mechanisms by which polymorphisms affect diseases.

2,281 European ancestry systemic sclerosis cases, 1,988 European ancestry Crohn’s disease cases, 7,388 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

24890
Total Participants
GWAS
Study Type
Yes
Replicated
3,453 European ancestry systemic sclerosis cases, 2,600 European ancestry Crohn’s disease cases, 7,180 European ancestry controls
Replication Participants
European
Ancestry
Germany, Netherlands, Spain, U.K., U.S., Italy
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.